-
Stocks in Focus: Tobira Therapeutics (NASDAQ:TBRA), PTC Therapeutics (NASDAQ:PTCT), Johnson & Johnson (NYSE:JNJ), Dex Media (NASDAQ:DXM), Stemline Therapeutics (NASDAQ:STML)
On Monday shares of Tobira Therapeutics, Inc. (NASDAQ:TBRA) closed at $13.97. Tobira Therapeutics, Inc. (NASDAQ:TBRA) announced on 4 May, the completion of its merger with Regado Biosciences, Inc. (NASDAQ: RGDO, through May 4). In conjunction with the closing of the merger, Tobira raised $40 million of common stock from a combination of new investors and…
-
Stocks in News: Stemline Therapeutics (NASDAQ:STML), AbbVie Inc. (NYSE:ABBV), Natuzzi SpA (NYSE:NTZ), Rayonier Inc. (NYSE:RYN), HEALTHSOUTH Corp. (NYSE:HLS)
On Friday shares of Stemline Therapeutics, Inc. (NASDAQ:STML) closed at $13.43. Stemline Therapeutics (NASDAQ:STML) was downgraded by Zacks from a “buy” rating to a “hold” rating in a research note issued on Wednesday. On Friday shares of AbbVie Inc. (NYSE:ABBV) closed at $65.99. Company’s sales growth for last 5 years was 7.00% and EPS growth…
-
Stocks in Focus: Oncothyreon Inc (NASDAQ:ONTY), PROS Holdings (NYSE:PRO), Mannatech, Incorporated (NASDAQ:MTEX), Stemline Therapeutics (NASDAQ:STML), Carrizo Oil & Gas Inc. (NASDAQ:CRZO)
On Thursday shares of Oncothyreon Inc (NASDAQ:ONTY) closed at $2.02. On May 11, 2015 Oncothyreon Inc. (NASDAQ:ONTY) reported financial results for the first quarter ended March 31, 2015. Net loss for the three months ended March 31, 2015 was $7.9 million, or $0.08 per basic and diluted share, compared with a net loss of $9.6…
-
Eye Catching Stocks: Endocyte (NASDAQ:ECYT), Stemline Therapeutics (NASDAQ:STML), Comcast Corporation (NASDAQ:CMCSA), Integra LifeSciences Holdings Corporation (NASDAQ:IART), AXIS Capital Holdings (NYSE:AXS)
On Thursday shares of Endocyte, Inc. (NASDAQ:ECYT) closed at $6.02. Company’s sales growth for last 5 years was 88.00%. Endocyte, Inc. (NASDAQ:ECYT) on 7 May, announced financial results for the first quarter ending March 31, 2015, and provided a clinical update. Cash, cash equivalents and investments were $196.8 million at March 31, 2015, compared to…
-
Investors Watch List: Stemline Therapeutics (NASDAQ:STML), BLUEPRINT MEDICINES CORP (NASDAQ:BPMC), AcelRx Pharmaceuticals (NASDAQ:ACRX), Akorn (NASDAQ:AKRX), ABM Industries Incorporated (NYSE:ABM)
On Tuesday shares of Stemline Therapeutics, Inc. (NASDAQ:STML) closed at $13.43. Stemline Therapeutics Inc. (STML) on Monday reported a loss of $7.7 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 46 cents. BLUEPRINT MEDICINES CORP (NASDAQ:BPMC) in last trading activity moved up 0.34% to…
-
Trending Stocks: Spirit Realty Capital (NYSE:SRC), Stemline Therapeutics (NASDAQ:STML), Q2 Holdings (NYSE:QTWO), Synaptics Inc. (NASDAQ:SYNA), Photronics Inc. (NASDAQ:PLAB)
On Monday shares of Spirit Realty Capital, Inc. (NYSE:SRC) closed at $11.15. Company’s sales growth for last 5 years was 16.80% and EPS growth for next 5 years is recorded as 5.00%. Zacks upgraded shares of Spirit Realty Capital, Inc (New) (NYSE:SRC) from a sell rating to a hold rating in a report released on…
-
Hot News: Stemline Therapeutics (NASDAQ:STML), Rite Aid Corporation (NYSE:RAD), Microsoft Corporation (NASDAQ:MSFT), Monroe Capital Corporation (NASDAQ:MRCC), Phoenix New Media Limited (NYSE:FENG)
On Monday shares of Stemline Therapeutics, Inc. (NASDAQ:STML) closed at $13.60. Stemline Therapeutics Inc. (NASDAQ:STML) on Monday reported a loss of $7.7 million in its first quarter. On a per-share basis, the New York-based company said it had a loss of 46 cents. The results missed Wall Street expectations. The average estimate of five analysts…
-
Hot News: Sage Therapeutics (NASDAQ:SAGE), Stemline Therapeutics (NASDAQ:STML), Banco Santander Brasil SA (ADR) (NYSE:BSBR), Riverview Bancorp (NASDAQ:RVSB), AuRico Gold (NYSE:AUQ)
On Thursday shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) closed at $54.86. SAGE Therapeutics (NASDAQ:SAGE), announced that the company will host a conference call and live webcast on Thursday, May 14, 2015 at 8:30 a.m. ET to report its financial results for the first quarter 2015 and discuss recent business updates. Stemline Therapeutics, Inc. (NASDAQ:STML) in…
-
Hot Stock List: Eastman Chemical Co. (NYSE:EMN), Public Storage (NYSE:PSA), Ariad Pharmaceuticals (NASDAQ:ARIA), Compass Diversified (NYSE:CODI), Caesars Acquisition (NASDAQ:CACQ), Stemline Therapeutics (NASDAQ:STML)
On Thursday shares of Eastman Chemical Co. (NYSE:EMN) closed at $76.22. Company’s sales growth for last 5 years was 16.70% and EPS growth for next 5 years is recorded as 8.04%. Eastman Chemical Co. (NYSE:EMN) reported net income for the first quarter of $171 million or $1.14 per share, compared to $233 million or $1.52…
-
5 Stocks Under Wall Street’s Radar: McDonald’s Corp. (NYSE:MCD), Stemline Therapeutics (NASDAQ:STML), Halcon Resources (NYSE:HK), German American Bancorp (NASDAQ:GABC), QuinStreet (NASDAQ:QNST)
On Thursday shares of McDonald’s Corp. (NYSE:MCD) closed at $96.55. Company’s sales growth for last 5 years was 3.80% and EPS growth for next 5 years is recorded as 5.90%. McDonald’s Corp. (NYSE:MCD) plans to raise wages starting this summer at the roughly 1,500 U.S. restaurants it owns, though the move won’t apply to the…